NFKB1 and breast cancer: These results seminally suggest that NFκB-mediated PEDF downregulation under post-menopausal oestrogen conditions in BC may enhance activation of pro-metastatic pathways, which may be relevant to BC bone metastasis in post-menopausal BC patients.